U.S. Markets closed

Biocept, Inc. (BIOC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.3200-0.1100 (-2.48%)
At close: 4:00PM EDT
4.2700 -0.05 (-1.16%)
After hours: 06:24PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.83
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 313.0000
52 Week Low 33.4600
50-Day Moving Average 34.5085
200-Day Moving Average 35.2869

Share Statistics

Avg Vol (3 month) 3358.49k
Avg Vol (10 day) 3169.6k
Shares Outstanding 513.4M
Implied Shares Outstanding 6N/A
Float 13.4M
% Held by Insiders 10.02%
% Held by Institutions 110.87%
Shares Short (Apr 14, 2021) 4774.73k
Short Ratio (Apr 14, 2021) 41.23
Short % of Float (Apr 14, 2021) 45.78%
Short % of Shares Outstanding (Apr 14, 2021) 45.78%
Shares Short (prior month Mar 14, 2021) 4574.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 07, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sep 07, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -64.84%
Operating Margin (ttm)-56.33%

Management Effectiveness

Return on Assets (ttm)-29.66%
Return on Equity (ttm)-102.07%

Income Statement

Revenue (ttm)27.46M
Revenue Per Share (ttm)2.32
Quarterly Revenue Growth (yoy)937.80%
Gross Profit (ttm)6.12M
EBITDA -14.38M
Net Income Avi to Common (ttm)-17.81M
Diluted EPS (ttm)-1.5040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.37M
Total Cash Per Share (mrq)1.07
Total Debt (mrq)12.23M
Total Debt/Equity (mrq)51.61
Current Ratio (mrq)2.61
Book Value Per Share (mrq)1.77

Cash Flow Statement

Operating Cash Flow (ttm)-19.79M
Levered Free Cash Flow (ttm)-14.75M